Сочетание саркоидоза и первичного билиарного холангита у пациентки с синдромом холестаза - Журнал Терапевтический архив №2 Вопросы гастроэнтерологии 2021
Сочетание саркоидоза и первичного билиарного холангита у пациентки с синдромом холестаза
Бровко М.Ю., Акулкина Л.А., Калашников М.В. и др. Сочетание саркоидоза и первичного билиарного холангита у пациентки с синдромом холестаза. Терапевтический архив. 2021; 93 (2): 193–198. DOI: 10.26442/00403660.2021.02.200620
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Первичный билиарный холангит и саркоидоз относятся к группе заболеваний печени, протекающих с преобладанием синдрома холестаза. Дифференциальная диагностика этих двух патологий основывается на совокупности данных анамнеза, а также объективного, лабораторного и инструментального обследования. Представленное наблюдение демонстрирует редкое сочетание у пациентки морфологически верифицированного поражения печени в рамках первичного билиарного холангита и саркоидоза. Несмотря на схожесть клинических проявлений, подходы к терапии данных заболеваний кардинально отличаются друг от друга, что указывает на необходимость исключения сочетанного поражения печени в сложных диагностических случаях.
Ключевые слова: первичный билиарный холангит, саркоидоз, холестаз
Keywords: primary biliary cholangitis, sarcoidosis, cholestasis
Ключевые слова: первичный билиарный холангит, саркоидоз, холестаз
________________________________________________
Keywords: primary biliary cholangitis, sarcoidosis, cholestasis
Список литературы
1. Hirschfield GM, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1);145-72. doi: 10.1016/j.jhep.2017.03.022
2. Valeyre D, Prasse A, NunesHet al. Sarcoidosis. Lancet. 2014;383(9923):1155-67. doi: 10.1016/S0140-6736(13)60680-7
3. Саркоидоз. Клинические рекомендации. Под ред. Н.А. Мухина. М.: ИМА-пресс, 2009; с. 54 [Sarkoidoz. Klinicheskie rekomendatsii. Pod red. N.A. Mukhina. Moscow: IMA-PRESS, 2009; p. 54 (In Russ.)].
4. Rajoriya N, Wotton CJ, Yeates DG, et al. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J. 2009;85(2003):233-7. doi: 10.1136/pgmj.2008.067769
5. Kishor S, Turner ML, Borg BB, et al. Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases? J Am Acad Dermatol. 2008;58(2):326-35. doi: 10.1016/j.jaad.2007.07.031
6. Hughes P, McGavin CR. Sarcoidosis and primary biliary cirrhosis with co-existing myositis. Thorax. 1997;52(2):201-2. doi: 10.1136/thx.52.2.201
7. Stanca CM, Fiel MI, Allina J, et al. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis. 2005;25(3):364-70. doi: 10.1055/s-2005-916327
8. Karlish AJ, Thompson RP, Williams R. A case of sarcoidosis and primary biliary cirrhosis. Lancet. 1969;2(7620):599. doi: 10.1016/s0140-6736(69)90306-7
9. Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med. 1975;59(3):373-87. doi: 10.1016/0002-9343(75)90396-4
10. Fagan EA, Moore-Gillon JC, Turner-Warwick M. Multiorgan granulomas and mitochondrial antibodies. N EngI J Med. 1983;308(10):572-5. doi: 10.1056/NEJM198303103081006
11. Zissel G, Prasse A., Müller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):390-403. doi: 10.1055/s-0030-1262208
12. Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon. 2009;55:675-92. doi: 10.1016/j.disamonth.2009.05.002
13. Alempijević T, Sokić-Milutinović A, Toncev L, et al. Primary biliary cirrhosis and hepatic sarcoidosis – a case report. Vojnosanit Pregl. 2014;71(1):83-6. doi: 10.2298/vsp1401083a
14. Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepaticsarcoidosis. Ann Hepatol. 2006;5(4):251-6. doi: 10.1016/S1665-2681(19)31983-0
15. Prince MI, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002;123:1044-51. doi: 10.1053/gast.2002.36027
16. Syed U, Alkhawam H, Bakhit M, et al. Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options. Scand J Gastroenterol. 2016;51(9):1025-30. doi: 10.1080/00365521.2016.1177856
17. Farouj NE, Cadranel JF D, Mofredj A, et al. Ductopenia related liver sarcoidosis. World J Hepatol. 2011;3(6):170-4. doi: 10.4254/wjh.v3.i6.170
18. Younossi ZM, Bernstein D, Shiffman ML, et al. Diagnosis and Management of Primary Biliary Cholangitis. Am J Gastroenterol. 2019;114(1):48-63. doi: 10.1038/s41395-018-0390-3
19. Ayyala U, Padilla M. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol. 2006;9(6):475-83. doi: 10.1007/s11938-006-0004-9
20. Martusewicz-Boros MM, Boros PW, Wiatr E. Respiratory system involvement in chronic liver diseases. Pol Arch Med Wewn. 2013;123:635-42. doi: 10.20452/pamw.1980
21. Koksal D, Koksal AS, Gurakar A. Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis. J Clin Transl Hepatol. 2016;4:258-62. doi: 10.14218/JCTH.2016.00024
2. Valeyre D, Prasse A, NunesHet al. Sarcoidosis. Lancet. 2014;383(9923):1155-67. doi: 10.1016/S0140-6736(13)60680-7
3. Sarkoidoz. Klinicheskie rekomendatsii. Pod red. N.A. Mukhina. Moscow: IMA-PRESS, 2009; p. 54 (In Russ.)
4. Rajoriya N, Wotton CJ, Yeates DG, et al. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J. 2009;85(2003):233-7. doi: 10.1136/pgmj.2008.067769
5. Kishor S, Turner ML, Borg BB, et al. Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases? J Am Acad Dermatol. 2008;58(2):326-35. doi: 10.1016/j.jaad.2007.07.031
6. Hughes P, McGavin CR. Sarcoidosis and primary biliary cirrhosis with co-existing myositis. Thorax. 1997;52(2):201-2. doi: 10.1136/thx.52.2.201
7. Stanca CM, Fiel MI, Allina J, et al. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis. 2005;25(3):364-70. doi: 10.1055/s-2005-916327
8. Karlish AJ, Thompson RP, Williams R. A case of sarcoidosis and primary biliary cirrhosis. Lancet. 1969;2(7620):599. doi: 10.1016/s0140-6736(69)90306-7
9. Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med. 1975;59(3):373-87. doi: 10.1016/0002-9343(75)90396-4
10. Fagan EA, Moore-Gillon JC, Turner-Warwick M. Multiorgan granulomas and mitochondrial antibodies. N EngI J Med. 1983;308(10):572-5. doi: 10.1056/NEJM198303103081006
11. Zissel G, Prasse A., Müller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):390-403. doi: 10.1055/s-0030-1262208
12. Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon. 2009;55:675-92. doi: 10.1016/j.disamonth.2009.05.002
13. Alempijević T, Sokić-Milutinović A, Toncev L, et al. Primary biliary cirrhosis and hepatic sarcoidosis – a case report. Vojnosanit Pregl. 2014;71(1):83-6. doi: 10.2298/vsp1401083a
14. Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepaticsarcoidosis. Ann Hepatol. 2006;5(4):251-6. doi: 10.1016/S1665-2681(19)31983-0
15. Prince MI, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002;123:1044-51. doi: 10.1053/gast.2002.36027
16. Syed U, Alkhawam H, Bakhit M, et al. Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options. Scand J Gastroenterol. 2016;51(9):1025-30. doi: 10.1080/00365521.2016.1177856
17. Farouj NE, Cadranel JF D, Mofredj A, et al. Ductopenia related liver sarcoidosis. World J Hepatol. 2011;3(6):170-4. doi: 10.4254/wjh.v3.i6.170
18. Younossi ZM, Bernstein D, Shiffman ML, et al. Diagnosis and Management of Primary Biliary Cholangitis. Am J Gastroenterol. 2019;114(1):48-63. doi: 10.1038/s41395-018-0390-3
19. Ayyala U, Padilla M. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol. 2006;9(6):475-83. doi: 10.1007/s11938-006-0004-9
20. Martusewicz-Boros MM, Boros PW, Wiatr E. Respiratory system involvement in chronic liver diseases. Pol Arch Med Wewn. 2013;123:635-42. doi: 10.20452/pamw.1980
21. Koksal D, Koksal AS, Gurakar A. Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis. J Clin Transl Hepatol. 2016;4:258-62. doi: 10.14218/JCTH.2016.00024
2. Valeyre D, Prasse A, NunesHet al. Sarcoidosis. Lancet. 2014;383(9923):1155-67. doi: 10.1016/S0140-6736(13)60680-7
3. Саркоидоз. Клинические рекомендации. Под ред. Н.А. Мухина. М.: ИМА-пресс, 2009; с. 54 [Sarkoidoz. Klinicheskie rekomendatsii. Pod red. N.A. Mukhina. Moscow: IMA-PRESS, 2009; p. 54 (In Russ.)].
4. Rajoriya N, Wotton CJ, Yeates DG, et al. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J. 2009;85(2003):233-7. doi: 10.1136/pgmj.2008.067769
5. Kishor S, Turner ML, Borg BB, et al. Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases? J Am Acad Dermatol. 2008;58(2):326-35. doi: 10.1016/j.jaad.2007.07.031
6. Hughes P, McGavin CR. Sarcoidosis and primary biliary cirrhosis with co-existing myositis. Thorax. 1997;52(2):201-2. doi: 10.1136/thx.52.2.201
7. Stanca CM, Fiel MI, Allina J, et al. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis. 2005;25(3):364-70. doi: 10.1055/s-2005-916327
8. Karlish AJ, Thompson RP, Williams R. A case of sarcoidosis and primary biliary cirrhosis. Lancet. 1969;2(7620):599. doi: 10.1016/s0140-6736(69)90306-7
9. Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med. 1975;59(3):373-87. doi: 10.1016/0002-9343(75)90396-4
10. Fagan EA, Moore-Gillon JC, Turner-Warwick M. Multiorgan granulomas and mitochondrial antibodies. N EngI J Med. 1983;308(10):572-5. doi: 10.1056/NEJM198303103081006
11. Zissel G, Prasse A., Müller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):390-403. doi: 10.1055/s-0030-1262208
12. Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon. 2009;55:675-92. doi: 10.1016/j.disamonth.2009.05.002
13. Alempijević T, Sokić-Milutinović A, Toncev L, et al. Primary biliary cirrhosis and hepatic sarcoidosis – a case report. Vojnosanit Pregl. 2014;71(1):83-6. doi: 10.2298/vsp1401083a
14. Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepaticsarcoidosis. Ann Hepatol. 2006;5(4):251-6. doi: 10.1016/S1665-2681(19)31983-0
15. Prince MI, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002;123:1044-51. doi: 10.1053/gast.2002.36027
16. Syed U, Alkhawam H, Bakhit M, et al. Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options. Scand J Gastroenterol. 2016;51(9):1025-30. doi: 10.1080/00365521.2016.1177856
17. Farouj NE, Cadranel JF D, Mofredj A, et al. Ductopenia related liver sarcoidosis. World J Hepatol. 2011;3(6):170-4. doi: 10.4254/wjh.v3.i6.170
18. Younossi ZM, Bernstein D, Shiffman ML, et al. Diagnosis and Management of Primary Biliary Cholangitis. Am J Gastroenterol. 2019;114(1):48-63. doi: 10.1038/s41395-018-0390-3
19. Ayyala U, Padilla M. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol. 2006;9(6):475-83. doi: 10.1007/s11938-006-0004-9
20. Martusewicz-Boros MM, Boros PW, Wiatr E. Respiratory system involvement in chronic liver diseases. Pol Arch Med Wewn. 2013;123:635-42. doi: 10.20452/pamw.1980
21. Koksal D, Koksal AS, Gurakar A. Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis. J Clin Transl Hepatol. 2016;4:258-62. doi: 10.14218/JCTH.2016.00024
________________________________________________
2. Valeyre D, Prasse A, NunesHet al. Sarcoidosis. Lancet. 2014;383(9923):1155-67. doi: 10.1016/S0140-6736(13)60680-7
3. Sarkoidoz. Klinicheskie rekomendatsii. Pod red. N.A. Mukhina. Moscow: IMA-PRESS, 2009; p. 54 (In Russ.)
4. Rajoriya N, Wotton CJ, Yeates DG, et al. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J. 2009;85(2003):233-7. doi: 10.1136/pgmj.2008.067769
5. Kishor S, Turner ML, Borg BB, et al. Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases? J Am Acad Dermatol. 2008;58(2):326-35. doi: 10.1016/j.jaad.2007.07.031
6. Hughes P, McGavin CR. Sarcoidosis and primary biliary cirrhosis with co-existing myositis. Thorax. 1997;52(2):201-2. doi: 10.1136/thx.52.2.201
7. Stanca CM, Fiel MI, Allina J, et al. Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis. 2005;25(3):364-70. doi: 10.1055/s-2005-916327
8. Karlish AJ, Thompson RP, Williams R. A case of sarcoidosis and primary biliary cirrhosis. Lancet. 1969;2(7620):599. doi: 10.1016/s0140-6736(69)90306-7
9. Rudzki C, Ishak KG, Zimmerman HJ. Chronic intrahepatic cholestasis of sarcoidosis. Am J Med. 1975;59(3):373-87. doi: 10.1016/0002-9343(75)90396-4
10. Fagan EA, Moore-Gillon JC, Turner-Warwick M. Multiorgan granulomas and mitochondrial antibodies. N EngI J Med. 1983;308(10):572-5. doi: 10.1056/NEJM198303103081006
11. Zissel G, Prasse A., Müller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):390-403. doi: 10.1055/s-0030-1262208
12. Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon. 2009;55:675-92. doi: 10.1016/j.disamonth.2009.05.002
13. Alempijević T, Sokić-Milutinović A, Toncev L, et al. Primary biliary cirrhosis and hepatic sarcoidosis – a case report. Vojnosanit Pregl. 2014;71(1):83-6. doi: 10.2298/vsp1401083a
14. Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepaticsarcoidosis. Ann Hepatol. 2006;5(4):251-6. doi: 10.1016/S1665-2681(19)31983-0
15. Prince MI, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology. 2002;123:1044-51. doi: 10.1053/gast.2002.36027
16. Syed U, Alkhawam H, Bakhit M, et al. Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options. Scand J Gastroenterol. 2016;51(9):1025-30. doi: 10.1080/00365521.2016.1177856
17. Farouj NE, Cadranel JF D, Mofredj A, et al. Ductopenia related liver sarcoidosis. World J Hepatol. 2011;3(6):170-4. doi: 10.4254/wjh.v3.i6.170
18. Younossi ZM, Bernstein D, Shiffman ML, et al. Diagnosis and Management of Primary Biliary Cholangitis. Am J Gastroenterol. 2019;114(1):48-63. doi: 10.1038/s41395-018-0390-3
19. Ayyala U, Padilla M. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol. 2006;9(6):475-83. doi: 10.1007/s11938-006-0004-9
20. Martusewicz-Boros MM, Boros PW, Wiatr E. Respiratory system involvement in chronic liver diseases. Pol Arch Med Wewn. 2013;123:635-42. doi: 10.20452/pamw.1980
21. Koksal D, Koksal AS, Gurakar A. Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis. J Clin Transl Hepatol. 2016;4:258-62. doi: 10.14218/JCTH.2016.00024
Авторы
М.Ю. Бровко1, Л.А. Акулкина1, М.В. Калашников1, Т.П. Розина1,2, Т.П. Некрасова1, В.И. Шоломова1,2, Д.В. Коновалов1, А.Ш. Янакаева1, С.В. Моисеев1,2
1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
2 ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова», Москва, Россия
1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
2 Lomonosov Moscow State University, Moscow, Russia
1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
2 ФГБОУ ВО «Московский государственный университет им. М.В. Ломоносова», Москва, Россия
________________________________________________
1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia;
2 Lomonosov Moscow State University, Moscow, Russia
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.